Herbert R. Lamche

714 total citations
18 papers, 542 citations indexed

About

Herbert R. Lamche is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Herbert R. Lamche has authored 18 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Herbert R. Lamche's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Herbert R. Lamche is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Herbert R. Lamche collaborates with scholars based in Austria, Germany and United States. Herbert R. Lamche's co-authors include Elínborg Ostermann, Guenther R. Adolf, Wolfgang J. Rettig, Christina Puri, M. Kalat, Pilar Garin‐Chesa, Dontscho Kerjaschki, Günther R. Adolf, Dale E. Hammerschmidt and Eric Borges and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Immunological Methods.

In The Last Decade

Herbert R. Lamche

18 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert R. Lamche Austria 9 249 194 163 92 71 18 542
Leander Blaas Austria 12 320 1.3× 496 2.6× 82 0.5× 79 0.9× 18 0.3× 17 805
Naira E. Souleimanian United States 12 202 0.8× 531 2.7× 724 4.4× 101 1.1× 56 0.8× 14 1.2k
Marille E. Herrmann United States 12 147 0.6× 279 1.4× 75 0.5× 43 0.5× 66 0.9× 23 600
Christophe Ronsin France 12 154 0.6× 472 2.4× 317 1.9× 47 0.5× 43 0.6× 13 925
Vijaya Iragavarapu‐Charyulu United States 15 273 1.1× 425 2.2× 387 2.4× 100 1.1× 16 0.2× 23 772
Shunsuke Yamamoto Japan 13 139 0.6× 316 1.6× 154 0.9× 107 1.2× 26 0.4× 22 678
Marsha Grattan Canada 11 312 1.3× 378 1.9× 255 1.6× 185 2.0× 21 0.3× 12 871
V von Tscharner Switzerland 5 167 0.7× 152 0.8× 301 1.8× 21 0.2× 38 0.5× 7 507
Tammy Sobolik-Delmaire United States 8 309 1.2× 333 1.7× 244 1.5× 78 0.8× 20 0.3× 9 662
Xiulan Qi United States 10 173 0.7× 200 1.0× 467 2.9× 50 0.5× 49 0.7× 16 786

Countries citing papers authored by Herbert R. Lamche

Since Specialization
Citations

This map shows the geographic impact of Herbert R. Lamche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert R. Lamche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert R. Lamche more than expected).

Fields of papers citing papers by Herbert R. Lamche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert R. Lamche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert R. Lamche. The network helps show where Herbert R. Lamche may publish in the future.

Co-authorship network of co-authors of Herbert R. Lamche

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert R. Lamche. A scholar is included among the top collaborators of Herbert R. Lamche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert R. Lamche. Herbert R. Lamche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Friedbichler, Katrin, Marco H. Hofmann, Elínborg Ostermann, et al.. (2013). Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin. Molecular Cancer Therapeutics. 13(2). 399–409. 73 indexed citations
2.
Heider, Karl‐Heinz, et al.. (2012). A Novel Fc-Engineered Antibody to CD33 with Enhanced ADCC Activity for Treatment of AML. Blood. 120(21). 1363–1363. 3 indexed citations
3.
Adam, Paul J., Elínborg Ostermann, Herbert R. Lamche, et al.. (2011). Abstract A208: Pharmacodynamic properties and antitumor efficacy of BI 836845, a fully human IGF ligand neutralizing antibody.. Molecular Cancer Therapeutics. 10(11_Supplement). A208–A208. 2 indexed citations
4.
Heider, Karl‐Heinz, Kerstin Kiefer, Thorsten Zenz, et al.. (2011). A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies. Blood. 118(15). 4159–4168. 78 indexed citations
5.
Heider, Karl‐Heinz, Elínborg Ostermann, Herbert R. Lamche, et al.. (2010). Novel Fc-Engineered Antibodies to CD37 with Pro-Apoptotic and Enhanced ADCC Activity. Blood. 116(21). 3916–3916. 1 indexed citations
6.
Ostermann, Elínborg, Pilar Garin‐Chesa, M. Kalat, et al.. (2008). Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts. Clinical Cancer Research. 14(14). 4584–4592. 197 indexed citations
7.
Steinmann, Gerhard, F. Rosenkaimer, Günther R. Adolf, et al.. (1992). Low incidence of antibody formation due to long-term interferon-?2c treatment of cancer patients. Journal of Molecular Medicine. 70(2). 136–41. 7 indexed citations
8.
Adolf, Günther R. & Herbert R. Lamche. (1990). Highly sensitive enzyme immunoassay for human lymphotoxin (tumor necrosis factor β) in serum. Journal of Immunological Methods. 130(2). 177–185. 3 indexed citations
9.
Redl, Heinz, G Schlag, & Herbert R. Lamche. (1990). TNF- and LPS-induced changes of lung vascular permeability: studies in unanesthetised sheep.. PubMed. 31(2). 183–92. 8 indexed citations
10.
Lamche, Herbert R., et al.. (1990). Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity. Inflammation. 14(1). 61–70. 25 indexed citations
11.
Lamche, Herbert R. & Günther R. Adolf. (1990). Highly sensitive enzyme immunoassays for antibodies to human tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β). Journal of Immunological Methods. 131(2). 283–289. 10 indexed citations
12.
Nadal, David, David Leppert, Karl Frei, et al.. (1989). Tumour necrosis factor-alpha in infectious meningitis.. Archives of Disease in Childhood. 64(9). 1274–1279. 62 indexed citations
13.
Redl, Heinz, et al.. (1989). TNF-induced organ changes in a chronic ovine model--possible role of leukocytes.. PubMed. 308. 467–83. 1 indexed citations
14.
Lamche, Herbert R., et al.. (1988). Development of a simple radioimmunoassay for human C3a. Inflammation. 12(3). 265–276. 1 indexed citations
15.
Hammerschmidt, Dale E., et al.. (1988). Inhibition of granulocyte function by steroids is not limited to corticoids. Inflammation. 12(3). 277–284. 19 indexed citations
16.
Redl, Heinz, et al.. (1987). Effect of methylprednisolone, prednisolone and dexamethasone on granulocyte function and complement activation.. PubMed. 236B. 261–72. 5 indexed citations
17.
Redl, Heinz, et al.. (1983). Aggregation, chemotaxis, and chemiluminescence of canine granulocytes. Inflammation. 7(1). 67–80. 39 indexed citations
18.
Redl, Heinz, Herbert R. Lamche, & G. Schlag. (1983). Red cell count dependence of whole blood granulocyte luminescence. Journal of Molecular Medicine. 61(3). 163–164. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leander Blaas Breakdown of academic impact, for papers by Naira E. Souleimanian Breakdown of academic impact, for papers by Marille E. Herrmann Breakdown of academic impact, for papers by Christophe Ronsin Breakdown of academic impact, for papers by Vijaya Iragavarapu‐Charyulu Breakdown of academic impact, for papers by Shunsuke Yamamoto Breakdown of academic impact, for papers by Marsha Grattan Breakdown of academic impact, for papers by V von Tscharner Breakdown of academic impact, for papers by Tammy Sobolik-Delmaire Breakdown of academic impact, for papers by Xiulan Qi
Rankless by CCL
2026